Abstract
Modeling and simulation (M&S) in physiologically-based pharmacokinetics (PBPK) studies have recently been recognized by American and European regulatory agencies for decision-making in drug development. This approach has been used to explore and quantitatively predict drug-drug interactions in virtual populations. In this study, modeling and simulation in PBPK will be used to predict the …